Recall: Hospira LifeCare IV Solutions

The FDA has announced a recall of many lots of many products in the Hospira LifeCare line of flexible intravenous solutions due to possible punctures.  Expect the recall to be upgraded to Class I (potential for serious injury or death), since puncture in the primary container may result in leakage that is difficult to detect; leakage may result in an open system, which has the potential for contamination, compromised sterility, drug waste, spillage, inadequate or inconsistent dosing, and/or delay in therapy, any of which may require medical intervention; and hazardous topical exposure may occur if a hazardous drug is added to the flexible container.

The recall notice is at http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm418887.htm and the list of products and lots at http://www.fda.gov/Safety/Recalls/ucm418879.htm.  Recalled products include Normosol-R Multiple Electrolytes, Sterile Water, and various combinations of Potassium Chloride, Dextrose, Sodium Chloride, and Lactated Ringer’s, all for Injection.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s